Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Regulator Wants Closer Ties With Health Technology Assessors

This article was originally published in The Pink Sheet Daily

Executive Summary

European Medicines Agency calls for increased collaboration with NICE-like bodies and other regulators.

You may also be interested in...



FDA, EMA Confidentiality Agreement Expanding Into "Clusters"

The "chatter" between reviewers and scientists at FDA and the European Medicines Agency appears to be increasing as the two bodies move toward renewing their confidential information sharing agreement

FDA, EMA Confidentiality Agreement Expanding Into "Clusters"

The "chatter" between reviewers and scientists at FDA and the European Medicines Agency appears to be increasing as the two bodies move toward renewing their confidential information sharing agreement

FDA Transparency Initiative: Disclosure Rules Could Expand, Then Be Harmonized

Following the release of FDA's Transparency Task Force report, the agency may want to add an agenda item to its harmonization discussions with EMA

Related Content

Topics

UsernamePublicRestriction

Register

PS070246

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel